Sony Pixel Power calrec Sony

July 31, 2025

01/08/2025

AI model detects hidden diabetes risk by reading glucose spikes Scripps Research scientists reveal how wearable sensors and artificial intelligence could transform the way we detect and manage pre-diabetes.

July 31, 2025

LA JOLLA, CA To diagnose either type 2 diabetes or pre-diabetes, clinicians typically rely on a lab value known as HbA1c. This test captures a person's average blood glucose levels over the previous few months. But HbA1c cannot predict who is at highest risk of progressing from healthy to prediabetic, or from prediabetic to full-blown diabetes.

Now, scientists at Scripps Research have discovered that artificial intelligence can use a combination of other data including real-time glucose levels from wearable monitors to provide a more nuanced view of diabetes risk.

The new model, described in Nature Medicine on July 31, 2025, uses continuous glucose monitor (CGM) data alongside gut microbiome, diet, physical activity and genetic information. It flags early signs of diabetes risk that standard HbA1c tests may miss.

We showed that two people with the same HbA1c score can have very different underlying risk profiles, says co-senior author Giorgio Quer, the director of artificial intelligence and assistant professor of Digital Medicine at Scripps Research. By bringing in more data how long glucose spikes take to resolve, what happens to glucose overnight, what is the food intake, and even what's happening in the gut we can start to tell who's on a fast track to diabetes and who isn't.

Ultimately, the goal of this work is to get a better understanding of what is driving diabetes progression and how we can intervene earlier in the clinic, adds co-senior author Ed Ramos, the senior director of digital clinical trials at Scripps Research.

While some variation in blood sugar is completely normal especially after eating frequent or exaggerated glucose spikes can be a sign that the body is struggling to manage sugar effectively. In healthy individuals, blood sugar typically rises and falls smoothly. But in people at risk for diabetes, these spikes can become sharper, more frequent or slower to resolve, even before routine lab tests like HbA1c pick up a problem. The new study shows that tracking these day-to-day dynamics provides a much more detailed view of a person's metabolic health, and might help identify trouble earlier.

The findings are a result of a multi-year, digital research program called the PRediction Of Glycemic RESponse Study, or PROGRESS. The study used social media outreach to enroll more than 1,000 people from across the U.S. in a fully remote clinical trial. Participants included people with diagnoses of either pre-diabetes or diabetes, as well as healthy individuals. For ten days, they wore Dexcom G6 CGMs, tracked their meals and exercise, and sent in samples of their blood, saliva and stool for testing. The researchers also had access to participants' electronic health records, which included previous lab values and diagnoses made by medical practitioners.

This was a really pioneering effort in the remote clinical trial space, says Ramos. We had to design a study that participants could complete entirely on their own from applying sensors to collecting and shipping biological samples without ever visiting a clinic. That level of self-guided participation required a completely different kind of infrastructure than usual.

Using the data, the researchers trained an AI model to distinguish people with type 2 diabetes from healthy individuals.

One of the clearest signals of diabetes risk that the researchers found was the time it takes for a blood sugar spike to return to normal. In people with type 2 diabetes, it often took 100 minutes or more for blood sugar to decrease after a spike, while healthier individuals returned to baseline much faster. The study also found that people with a more diverse gut microbiome and higher activity level tended to have better glucose control, while a higher resting heart rate was linked to diabetes.

Importantly, the AI model didn't just detect risk in people with already elevated HbA1c. When applied to pre-diabetic individuals, it found that some looked metabolically similar to those with diabetes, while others resembled healthy individuals, despite having similar lab values. This level of granularity could help clinicians personalize treatment focusing on lifestyle changes or early therapies for patients with the highest risk of disease progression.

While the current study was a snapshot in time, the researchers are continuing to follow participants to see whether the model's predictions translate to real-world disease progression. They also validated the model using a separate set of patient data from Israel, strengthening its potential for broader clinical use.

The team envisions future versions of the model being used by clinicians, or even individuals using CGMs at home, to assess metabolic risk and monitor how daily choices affect diabetes.

Ultimately, this is about giving people more insight and control, says Quer. Diabetes doesn't just appear one day it builds slowly, and we now have the tools to detect it earlier and intervene smarter.

In addition to Quer and Ramos, authors of the study, Multimodal A.I. correlates of glucose spikes in people with normal glucose regulation, pre-diabetes, and type 2 diabetes, include Mattia Carletti, Jay Pandit, Matteo Gadaleta, Danielle Chiang, Felipe Delgado, Katie Quartuccio, Brianna Fernandez, Juan Antonio Raygoza Garay, Ali Torkamani, Katie Baca-Motes, and Eric J. Topol of Scripps Research; Riccardo Miotto of Tempus AI; Hagai Rossman of Pheno.AI; Vik Kheterpal and Benjamin Berk of CareEvolution; Eran Segal of the Weizmann Institute of Science.

This study was supported by Tempus AI and the National Center for Advancing
LINK: https://www.scripps.edu/news-and-events/press-room/2025/20250731-progr...
See more stories from scripps

More from Scripps

08/08/2025

August 07, 2025

Researchers identify promising new compound to treat tuberculosis Study led by Scripps Research, Texas A&M and additional institutions highlights that the world...

01/08/2025

July 31, 2025

AI model detects hidden diabetes risk by reading glucose spikes Scripps Research scientists reveal how wearable sensors and artificial intelligence could transf...

23/07/2025

July 21, 2025

Where did RNA come from? Origin-of-life scientists from Scripps Research reveal how the sugar ribose may have been selected as one of life's building blocks...

19/06/2025

June 17, 2025

Calibr-Skaggs doses first patient with switchable CAR-T cell therapy in a phase 1 trial for metastatic breast cancer CLBR001 ABBV-461 is a novel, investigatio...

19/06/2025

June 18, 2025

Two-part vaccine strategy generates a stronger, longer-lasting immune boost against HIV Scripps Research scientists' new approach combines two immune-activa...

05/06/2025

June 04, 2025

FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease Cell-based therapy with roots at Scripps Research offers new ho...

04/06/2025

June 03, 2025

Females may be more biochemically sensitive to alcohol-long before dependence sets in Scripps Research's insights into sex-based differences in brain chemis...

30/05/2025

May 29, 2025

AI pinpoints new anti-aging drug candidates More than 70% of the drugs identified by artificial intelligence extended the lifespan of C. elegans worms. May 29,...

28/05/2025

May 27, 2025

HIV vaccine study uncovers powerful new antibody target Certain antibodies blocked nearly 70% of HIV strains, including those typically hard to target. May 27,...

23/05/2025

May 22, 2025

Newest building on Scripps Research campus earns LEED gold rating Chi-Huey Wong Laboratories for Biomedical Research recognized for sustainable construction. M...

20/05/2025

May 19, 2025

Genomic data shows widespread mpox transmission in West Africa prior to 2022 global outbreak Scripps Research scientists, in collaboration with researchers in N...

16/05/2025

May 15, 2025

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies North American and African clinical trials led by Scripps Research, ...

14/05/2025

May 13, 2025

Genome of near-extinct northern white rhino offers hope for reviving the species Breakthrough from Scripps Research, San Diego Zoo, Max Planck Institute and oth...

07/05/2025

May 06, 2025

Eric Topol authors book on the science of healthy aging Latest book by Scripps Research executive vice president guides readers through medical breakthroughs t...

29/04/2025

April 28, 2025

Origin of life twist: New study challenges longstanding hypothesis on how first sugars formed Scripps Research and Georgia Institute of Technology scientists...

22/04/2025

April 21, 2025

Empowering antibodies to better activate the immune system Scripps Research scientists discover that a higher ratio of antibodies to viral protein helps engage ...

17/04/2025

April 16, 2025

A better way to predict a patient's risk of coronary artery disease Scripps Research scientists developed a model that more accurately identifies patients a...

16/04/2025

April 15, 2025

The very first structural images of a tuberculosis-fighting virus New insights from Scripps Research could advance phage therapies for the world's deadliest...

10/04/2025

April 09, 2025

FDA clears IND for clinical trial testing switchable CAR-T therapy in patients with autoimmune diseases, without chemotherapy Innovative cellular therapy has po...

08/04/2025

April 07, 2025

A gentle approach offers new hope for inflammatory lung diseases Scripps Research and aTyr Pharma scientists have revealed how the protein HARSWHEP calms inflam...

02/04/2025

April 02, 2025

How microRNAs act as a blueprint for the developing brain Scripps Research scientists reveal that microRNAs guide the development of Purkinje cells, a rare ty...

25/03/2025

March 25, 2025

Low-sugar' vaccine can provide broad immunity against coronavirus variants Scripps Research chemistry professor Chi-Huey Wong presents results from his team...

21/03/2025

March 21, 2025

How scientists uncovered memory's hidden architecture New structural hallmarks of memory storage discovered by Scripps Research could lead to treatments for...

11/03/2025

March 10, 2025

Compound found in common herbs inspires potential anti-inflammatory drug for Alzheimer's disease Scripps Research scientists created a stable form of carnos...

04/03/2025

March 03, 2025

How a crucial DNA repair protein works-and what it means for cancer treatment New structural blueprint is key for better targeting cancer cells, particularly th...

28/02/2025

February 27, 2025

How air pollution and wildfire smoke may contribute to memory loss in Alzheimer's disease Scripps Research scientists discovered how a chemical modification...

07/02/2025

February 06, 2025

Collaboration awards enable scientists to design new medicines, more precisely edit DNA and fight drug-resistant bacteria Scripps Research announces its 2024 re...

29/01/2025

January 29, 2025

Researchers illuminate new structures of a critical amyloid protein Insights could advance new drugs to treat the progressive, fatal disease known as transthyre...

24/01/2025

January 23, 2025

Long-acting injectable malaria drug enters first-in-human study Calibr-Skaggs' long-acting injectable (LAI) platform transforms oral malaria treatment atova...

04/01/2025

January 03, 2025

Virtual chemistry speeds up drug discovery By using computer modeling to predict chemical reactions, Scripps Research scientists were able to synthesize 25 vari...

17/12/2024

December 16, 2024

Brain cells remain healthy after a month on the International Space Station, but mature faster than brain cells on Earth Scripps Research scientists reveal micr...

10/12/2024

December 09, 2024

Scripps Research scientists create AI that watches videos by mimicking the brain A new, more sustainable AI model recognizes visual scenes by mirroring brain ...

06/12/2024

December 05, 2024

Scripps Research scientists identify mutation that could facilitate H5N1 bird flu virus infection and potential transmission in humans New findings underscore...

05/12/2024

December 04, 2024

Scripps Research scientists receive up to $12M to create universal vaccine for alphaviruses Funding from ARPA-H will be used to develop a vaccine for alphavirus...

19/11/2024

November 19, 2024

Researchers use biophysics to design new vaccines against RSV and related respiratory viruses Scripps Research scientists improved existing vaccines by analyzin...

30/10/2024

October 30, 2024

Calibr-Skaggs announces initial dosing of a first-in-class regenerative lung medicine in a phase 1 trial for idiopathic pulmonary fibrosis CMR316 is a once-week...

24/10/2024

October 23, 2024

Human mini-brains reveal autism biology and potential treatments By creating personalized brain organoids in the lab, Scripps Research scientists showed how ...

16/10/2024

October 15, 2024

Scripps Research scientists discover chemical probes for previously undruggable cancer target Scientists uncover how small molecules interact with a cancer-re...

02/10/2024

October 01, 2024

Professor Stuart Lipton awarded $5 million to study the chemical biology of air pollution on the human brain The grant from the NIA/NIH will support research in...

01/10/2024

September 30, 2024

Seeing double: Designing drugs that target twin cancer proteins Scripps Research scientists used knowledge about a protein to characterize drugs that selectiv...

27/09/2024

September 25, 2024

Scripps Research scientist Ilia Droujinine receives over $3 million to reveal the body's interorgan networks The awards from the NIDDK and the LLHF will let...

20/09/2024

September 19, 2024

Genetic tracing at the Huanan Seafood market further supports COVID animal origins An international collaboration between Scripps Research, University of Arizon...

12/09/2024

September 11, 2024

Scripps Research scientists expand the genetic alphabet to create new proteins The novel method uses sets of four RNA nucleotides rather than the natural three ...

27/08/2024

August 26, 2024

New way to potentially slow cancer growth Using a combination of two protein-mapping methods, Scripps Research scientists uncover novel proteins that could be t...

22/08/2024

August 21, 2024

Gut molecule slows fat burning during fasting Scripps Research scientists discovered a molecule produced by roundworm intestines that signals the brain to slow ...

14/08/2024

March 11, 2024

Using wrist-worn activity trackers to help patients reduce long COVID symptoms New Scripps Research trial aims to validate the use of wearables in guiding parti...

09/08/2024

August 08, 2024

Scripps Research chemists develop new sustainable reaction for creating unique molecular building blocks The building blocks can be used to create polymers with...

26/07/2024

July 25, 2024

Timing matters: Scripps Research study shows ways to improve health alerts Wearable health sensors are a powerful tool in disease detection and in stemming the ...

17/07/2024

July 16, 2024

New sleep study aims to understand cognitive decline in women Scripps Research launches digital trial to identify sleep-related risk factors for Alzheimer's...

11/07/2024

July 09, 2024

Researchers identify brain region involved in oxycodone relapse Study by Scripps Research scientists suggests future therapies for opioid and alcohol addiction....